The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Chumovatov N.V.

Central Tuberculosis Research Institute

Chernyh N.A.

Central Tuberculosis Research Institute

Komissarova O.G.

Central Tuberculosis Research Institute

Romanov V.V.

Central Tuberculosis Research Institute

Lung tuberculosis and malignant neoplasms: the current state of the problem

Authors:

Chumovatov N.V., Chernyh N.A., Komissarova O.G., Romanov V.V.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2025;28(3): 122‑127

Read: 2427 times


To cite this article:

Chumovatov NV, Chernyh NA, Komissarova OG, Romanov VV. Lung tuberculosis and malignant neoplasms: the current state of the problem. Russian Journal of Preventive Medicine. 2025;28(3):122‑127. (In Russ.)
https://doi.org/10.17116/profmed202528031122

Recommended articles:
Surgical treatment of pulmonary tube­rculosis in children and adolescents. Piro­gov Russian Journal of Surgery. 2025;(3):16-23
Algo­rithms for morphological diagnostics of dysplastic nevus. P.A. Herzen Journal of Onco­logy. 2025;(2):83-88

References:

  1. World Health Organization. Cancer Today. Accessed December 19, 2024. https://gco.iarc.fr/today/home
  2. Moreira AL, Wang J, Tsenova-Berkova L, et al. Sequestration of Mycobacterium tuberculosis in tight vacuoles in vivo in lung macrophages of mice infected by the respiratory route. Infection and Immunity. 1997;65(1):305-308.  https://doi.org/10.1128/iai.65.1.305-308.1997
  3. Bhatt M, Kant S, Bhaskar R. Pulmonary tuberculosis as differential diagnosis of lung cancer. South Asian Journal Cancer. 2012;1(1):36-42.  https://doi.org/10.4103/2278-330X.96507
  4. Wei S, Shi B, Zhang J, et al. Differentiating mass-like tuberculosis from lung cancer based on radiomics and CT features. Translation Cancer Research. 2021;10(10):4454-4463. https://doi.org/10.21037/tcr-21-1719
  5. Preda M, Tănase BC, Zob DL, et al. The Bidirectional Relationship between Pulmonary Tuberculosis and Lung Cancer. International Journal of Environmental Research and Public Health. 2023;10;20(2):1282. https://doi.org/10.3390/ijerph20021282
  6. Cabrera-Sanchez J, Cuba V, Vega V, et al. Lung cancer occurrence after an episode of tuberculosis: a systematic review and meta-analysis. European Respiratory Review. 2022;27:31(165):220-225.  https://doi.org/10.1183/16000617.0025-2022
  7. Datta M, Via LE, Dartois V, et al. Leveraging insights from cancer to improve tuberculosis therapy. Trends in Molecular Medicine. 2024;13:1471-4914(24)00205-3.  https://doi.org/10.1016/j.molmed.2024.07.011
  8. Tobin DM. Host-Directed Therapies for Tuberculosis. Cold Spring Harbor Perspectives in Medicine. 2015;18;5(10):a021196. https://doi.org/10.1101/cshperspect.a021196
  9. Binnewies M, Roberts EW, Kersten K, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nature Medicine. 2018;24(5):541-550.  https://doi.org/10.1038/s41591-018-0014-x
  10. Bickett TE, Karam SD. Tuberculosis-Cancer Parallels in Immune Response Regulation. International Journal of Molecular Sciences. 2020:26;21(17):6136. https://doi.org/10.3390/ijms21176136
  11. Qin Y, Chen Y, Chen J, et al. The relationship between previous pulmonary tuberculosis and risk of lung cancer in the future. Infectious Agent and Cancer. 2022:7;17(1):20.  https://doi.org/10.1186/s13027-022-00434-2
  12. Malik AA, Sheikh JA, Ehtesham NZ, et al. Can Mycobacterium tuberculosis infection lead to cancer? Call for a paradigm shift in understanding TB and cancer. International Journal of Medical Microbiology. 2022;312(5): 151-158.  https://doi.org/10.1016/j.ijmm.2022.151558
  13. Villaseñor T, Madrid-Paulino E, Maldonado-Bravo R, et al. Activation of the Wnt Pathway by Mycobacterium tuberculosis: A Wnt-Wnt Situation. Frontiers in Immunology. 2017;1;8:50.  https://doi.org/10.3389/fimmu.2017.00050
  14. Ballaz S, Mulshine JL. The potential contributions of chronic inflammation to lung carcinogenesis. Clinical Lung Cancer. 2003;5(1):46-62.  https://doi.org/10.3816/CLC.2003.n.021
  15. Singh V, Jamwal S, Jain R, et al. Mycobacterium tuberculosis-driven targeted recalibration of macrophage lipid homeostasis promotes the foamy phenotype. Cell Host and Microbe. 2012;15;12(5):669-681.  https://doi.org/10.1016/j.chom.2012.09.012
  16. Ahmad F, Rani A, Alam A, et al. Macrophage: A Cell With Many Faces and Functions in Tuberculosis. Frontiers in Immunology. 2022:6;13:747-799.  https://doi.org/10.3389/fimmu.2022.747799
  17. Liang HY, Li XL, Yu XS, et al. Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review. International Journal of Cancer. 2009:15;125(12):2936-2944. https://doi.org/10.1002/ijc.24636
  18. Chai Q, Lu Z, Liu Z, et al. Lung gene expression signatures suggest pathogenic links and molecular markers for pulmonary tuberculosis, adenocarcinoma and sarcoidosis. Communications Biology. 2020;23;3(1):604.  https://doi.org/10.1038/s42003-020-01318-0
  19. Mahler B, de Vries G, van Hest R, et al. Use of targeted mobile X-ray screening and computer-aided detection software to identify tuberculosis among high-risk groups in Romania: descriptive results of the E-DETECT TB active case-finding project. BMJ Open. 2021;24;11(8):e045289. https://doi.org/10.1136/bmjopen-2020-045289
  20. Cicenas S, Vencevicius V. Lung cancer in patients with tuberculosis. World Journal of Surgical Oncology. 2007;19;5:22.  https://doi.org/10.1186/1477-7819-5-22
  21. Lee CS, Shu CC, Chen YC, et al. Tuberculosis treatment incompletion in patients with lung cancer: occurrence and predictors. International Journal of Infectious Diseases. 2021;113:200-206.  https://doi.org/10.1016/j.ijid.2021.09.072
  22. Parker CS, Siracuse CG, Litle VR. Identifying lung cancer in patients with active pulmonary tuberculosis. Journal of Thoracic Disease. 2018;10: 3392-3397. https://doi.org/10.21037/jtd.2018.07.11
  23. Hwang SY, Kim JY, Lee HS, et al. Pulmonary Tuberculosis and Risk of Lung Cancer: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2022;11(3):765.  https://doi.org/10.3390/jcm11030765
  24. Heuvers ME, Aerts JG, Hegmans JP, et al. History of tuberculosis as an independent prognostic factor for lung cancer survival. Lung Cancer. 2012; 76(3):452-456.  https://doi.org/10.1016/j.lungcan.2011.12.008
  25. Myakisheva TV, Idobaeva OP. Tuberculosis or cancer: causes of differential diagnostic errors. Vestnik Central’nogo nauchno-issledovatel’skogo instituta tuberkuleza. 2023;4:39-45. (In Russ.). https://doi.org/10.57014/2587-6678-2023-7-4-39-45
  26. Morales A, Eidinger D, Bruce AW. Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. The Journal of Urology. 1976;116:180-183.  https://doi.org/10.1016/s0022-5347(17)58737-6
  27. Pettenati C, Ingersoll MA. Mechanisms of BCG immunotherapy and its outlook for bladder cancer. Nature Reviews Urology. 2018;15(10):615-625.  https://doi.org/10.1038/s41585-018-0055-4

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.